Skip to main navigation

Home
Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Press Releases

Press Releases

Year

February 10, 2021

Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares

January 20, 2021

Athira Pharma Announces Pricing of Public Offering of Common Stock

January 19, 2021

Athira Pharma Announces Proposed Public Offering of Common Stock

January 7, 2021

Athira Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference

December 14, 2020

Athira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors

December 8, 2020

Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease

December 1, 2020

Athira Pharma Announces Initiation of Patient Dosing for ACT-AD Clinical Trial of ATH-1017, Small Molecule HGF/MET Activator, for Treatment of Mild-to-Moderate Alzheimer’s Disease

November 12, 2020

Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights

November 10, 2020

Athira Pharma to Present at Upcoming November Investor Conferences

October 21, 2020

Athira Pharma to Host Educational Webinar on the Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease Treatments

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Next page
Last page

Displaying 71 - 80 of 93

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

© Athira Pharma, Inc. All rights reserved.